TrialAntimicrobial agents and chemotherapy2012

Characterization of resistance to the protease inhibitor GS-9451 in hepatitis C virus-infected patients.

Hadas Dvory-Sobol et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.